Thermo Fisher Scientific Inc. [NYSE:TMO]: Analyst Rating and Earnings

Equities traders often pay a significant amount of attention to what top market analysts have to say about a potential stock investment. In regards to Thermo Fisher Scientific Inc. [TMO], the most recent average analyst recommendation we can read comes from the fiscal quarter ending in December. On average, stock market experts give TMO an Outperform rating. Its stock price has been found in the range of 202.83 to 282.98. This is compared to its latest closing price of $263.04.

Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Thermo Fisher Scientific Inc. [TMO] is sitting at 1.65. This is compared to 1 month ago, when its average rating was 1.65.

For the quarter ending in Mar-19 Thermo Fisher Scientific Inc. [TMO] generated $6.13 billion in sales. That’s 1.73% higher than the average estimate of $6.02 billion as provided by Wall Street analysts. The three indicators above suggest that overall, this stock is demonstrating a mixed bag of positive appeal and some drawbacks, making it a somewhat risky investment that also has the potential to generate high ROI in the long run.

Keep your eyes on this company’s next financial results, which are scheduled to be made public on Wed 24 Jul (In 69 Days).

Fundamental Analysis of Thermo Fisher Scientific Inc. [TMO]

Now let’s turn to look at profitability: with a current Operating Margin for Thermo Fisher Scientific Inc. [TMO] sitting at +15.90 and its Gross Margin at +45.11, this company’s Net Margin is now 12.90%. These measurements indicate that Thermo Fisher Scientific Inc. [TMO] is generating considerably more profit, after expenses are accounted for, compared to its market peers.

This company’s Return on Total Capital is 8.33, and its Return on Invested Capital has reached 7.40%. Its Return on Equity is 11.09, and its Return on Assets is 5.20. These metrics show a mixed bag, which means that this investment’s attractiveness can be quickly increased or decreased in the short term, depending on future updates TMO financial performance.

Turning to investigate this organization’s capital structure, Thermo Fisher Scientific Inc. [TMO] has generated a Total Debt to Total Equity ratio of 68.84. Similarly, its Total Debt to Total Capital is 40.77, while its Total Debt to Total Assets stands at 33.77. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 64.23, and its Long-Term Debt to Total Capital is 38.04. This company is not leveraging its assets to take on debt, which stunts its growth and limits the ROI for investors.

What about valuation? This company’s Enterprise Value to EBITDA is 20.29 and its Total Debt to EBITDA Value is 3.09. The Enterprise Value to Sales for this firm is now 5.06, and its Total Debt to Enterprise Value stands at 0.18. Thermo Fisher Scientific Inc. [TMO] has a Price to Book Ratio of 3.50, a Price to Cash Flow Ratio of 20.00 and P/E Ratio of 34.01. These metrics suggest that this publicly-traded organization will not likely result in investment gains.

Shifting the focus to workforce efficiency, Thermo Fisher Scientific Inc. [TMO] earns $347,971 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 5.47 and its Total Asset Turnover is 0.43. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 1.24 and its Current Ratio is 1.73. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Thermo Fisher Scientific Inc. [TMO] has 399.71M shares outstanding, amounting to a total market cap of $105.14B. Its stock price has been found in the range of 202.83 to 282.98. At its current price, it has moved by -5.79% from its 52-week high, and it has moved 31.44% from its 52-week low.

This stock’s Beta value is currently 1.13, which indicates that it is more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 46.90. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is Thermo Fisher Scientific Inc. [TMO] a Reliable Buy?

Shares of Thermo Fisher Scientific Inc. [TMO], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.